domvanalimab,etrumadenant,zimberelimab
otsuka,arcus biosciences,gilead
['arc-7', '$rcus', '$gild']
let's compare arc-7 in dec 2022 vs 6mths later #asco23 $gild $rcus 
Once had a blue tick. Journalist at Evaluate Vantage. Interested in: oncology, immunology. Not interested in: what stock you bought today.